Abansado, Daisy Joy .
HRN: 07-47-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2023
CEFUROXIME 500MG (TAB)
12/14/2023
12/21/2023
PO
500 Mg
BiD
2nd Degree RMLE
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes